Dallas / Pasadena / Boston / New York / Iowa City / Cambridge / Duarte / Durham / St. Louis / /
Company
Merck & Co. Inc. / Quark Pharmaceuticals Inc. / Alnylam Pharmaceuticals / Santaris Pharma A/S / Calando Pharmaceuticals Inc. / Supporting Technologies / /
Country
United States / United Kingdom / Denmark / /
Facility
University of Iowa / University of Rochester / University of Texas Southwestern Medical Center / New York University / National Cancer Institute / Children’s Hospital / Memorial Sloan-Kettering Cancer Center / EMERGING CLINICAL APPLICATIONS NATIONAL INSTITUTES OF HEALTH HILTON HOTEL / Massachusetts Institute of Technology / King's College / Duke University Medical Center / Beckman Research Institute / Yale University / University School / /
National Cancer Institute / Food and Drug Administration / University of Rochester / Rochester / Children’s Hospital Boston / Massachusetts Institute of Technology / King's College London / London / Recombinant DNA Advisory Committee / Yale University / University of Texas Southwestern Medical Center at Dallas / University School of Medicine / New York University / New York / Memorial Sloan-Kettering Cancer Center / FDA / Center for Drug Evaluation and Research / University of Iowa / Duke University Medical Center / Beckman Research Institute of the City / /
Person
Charles Thornton / David Bartel / Michael Templin / Sara Nochur / Thomas Schluep / Bryan Cullen / Silver Spring / Eric Hoffman / Natasha Caplen / Yuman Fong / Marina Biotech / Robert Dorsam / George Washington / Jared Gollob / Joshua Mendell / Carlos Fernandez-Hernando / Phillip Sharp / Adjourn Mark Boldin / Beverly L. Davidson / James Thompson / Michael Hodges / Morten Lindow / Frank Slack / John Rossi / Judy Lieberman / Gerald Dorn / Andrew Miller / Memorial Sloan-Kettering / /
Position
Chair / /
ProvinceOrState
New York / Iowa / Massachusetts / /
RadioStation
AM 10 / /
Technology
proteomics / Bioinformatics / siRNA / Recombinant DNA / /